| Not Yet Recruiting | To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets . NCT07534176 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Oral Antioxidant Therapy Targeted to the Mitochondria for Improving Brain Artery Health in Postmenopausal Wome NCT07406243 | Colorado State University | N/A |
| Not Yet Recruiting | The Effect of EX-PLISSIT Model-Based Sexual Counseling in Postmenopausal Women NCT07283146 | NESLİHAN YILMAZ SEZER | N/A |
| Not Yet Recruiting | Resting Energy Expenditure in Postmenopausal Women NCT06905886 | Insel Gruppe AG, University Hospital Bern | — |
| Recruiting | GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women NCT06813261 | Buck Institute for Research on Aging | N/A |
| Active Not Recruiting | The Effect of Sujok Therapy on Urinary Incontinence and Quality of Life in Postmenopausal Women NCT06951022 | Inonu University | N/A |
| Recruiting | Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy NCT06309290 | Universidad de La Frontera | N/A |
| Recruiting | The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascu NCT05831709 | University Hospital, Ghent | N/A |
| Completed | Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer NCT05690295 | Universidad de La Frontera | N/A |
| Completed | MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making NCT05299983 | University of California, San Diego | N/A |
| Completed | The Effect of Counseling Based on the Roy Adaptation Model on Sexual Life and Quality of Life in Menopause NCT06605742 | Istanbul University | N/A |
| Unknown | HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding NCT04867109 | Nantes University Hospital | — |
| Completed | Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment NCT05347082 | Hospital Regional 1o de Octubre | N/A |
| Completed | Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome NCT05346445 | Hospital Regional 1o de Octubre | N/A |
| Completed | The Effect of Sexual Counseling Given According to the PLISSIT Model on FSFI, MAS and SQOL-F of Postmenopausal NCT05448079 | Suleyman Demirel University | N/A |
| Withdrawn | Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Po NCT03854396 | Olivia Cardenas-Trowers, M.D. | Phase 3 |
| Unknown | Diet for the Maintenance of Weight Loss and Metabolic Health in Obese Postmenopausal Women NCT04136093 | Poznan University of Life Sciences | N/A |
| Completed | Beetroot Supplementation in Women Enjoying Exercise Together NCT04370756 | Indiana University | N/A |
| Unknown | Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors. NCT03644329 | Universidade Federal do Triangulo Mineiro | N/A |
| Completed | Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women NCT02887885 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | The Effect of Mechanical Loading on Bone Material Strength and Microarchitecture in Postmenopausal Women NCT02339051 | Mattias Lorentzon | N/A |
| Completed | Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes NCT06115577 | Pirogov Russian National Research Medical University | — |
| Completed | Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women NCT01556737 | Wageningen University | N/A |
| Unknown | Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In NCT01338142 | Tel-Aviv Sourasky Medical Center | Phase 1 / Phase 2 |
| Completed | Effects of Isoflavones on Gene-expression NCT01232751 | Wageningen University | N/A |
| Completed | Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women NCT01432470 | PepTonic Medical AB | Phase 2 |
| Completed | A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive NCT01171417 | AstraZeneca | — |
| Completed | Effects of Breathing Training on Psychosocial Functioning and Heart Rate Variability in Postmenopausal Women W NCT01044563 | National Science and Technology Council, Taiwan | N/A |
| Withdrawn | Effects of Breathing Training on Psychosocial Functioning and Heart Rate Variability in Postmenopausal Women W NCT01045811 | National Science and Technology Council, Taiwan | N/A |
| Withdrawn | Effects of Breathing Training on Psychosocial Functioning and Heart Rate Variability in Postmenopausal Women W NCT01046149 | National Science and Technology Council, Taiwan | N/A |
| Terminated | Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugat NCT00847821 | Wyeth is now a wholly owned subsidiary of Pfizer | — |
| Completed | Study Evaluating Premarin and Bazedoxifene Potential Interaction NCT00745173 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women NCT00706225 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(C NCT00799708 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women NCT00543634 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Evaluating Bazedoxifene/CE in Postmenopausal Women NCT00550433 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Effects of Wellnara on Climacteric Symptoms NCT00913926 | Bayer | — |
| Completed | Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women NCT00901589 | Aalborg University Hospital | N/A |
| Completed | Endometrial Safety Study NCT00522873 | Bayer | Phase 3 |
| Completed | Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk NCT00574574 | University of East Anglia | N/A |
| Completed | Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro) NCT00472927 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms NCT00479778 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women NCT01432028 | Denusa Wiltgen | N/A |
| Completed | Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture NCT00425776 | Vejle Hospital | Phase 1 |
| Completed | Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypert NCT00420342 | Bayer | Phase 2 |
| Completed | Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women NCT00372099 | Rene Rizzoli | Phase 3 |
| Completed | PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE) NCT00515593 | Nycomed | — |
| Completed | Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation NCT00381251 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solut NCT00367536 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women NCT00384072 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination NCT00251082 | Solvay Pharmaceuticals | Phase 3 |
| Completed | Efficacy and Tolerability of Angeliq in Thai Women NCT00185328 | Bayer | Phase 4 |
| Completed | Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women NCT00484107 | Wyeth is now a wholly owned subsidiary of Pfizer | — |
| Completed | Insulin Resistance and Testosterone in Women NCT00123110 | University of Pennsylvania | Phase 2 |
| Completed | Acute Metabolic Effects of Estradiol NCT00435175 | University of Aarhus | N/A |
| Completed | Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women NCT00380887 | Wyeth is now a wholly owned subsidiary of Pfizer | — |
| Completed | Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination NCT00160316 | Solvay Pharmaceuticals | Phase 3 |
| Completed | Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women. NCT00195455 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Unknown | Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women NCT00235924 | Laboratoires Arkopharma | Phase 3 |
| Completed | Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women NCT00102141 | Bayer | Phase 3 |
| Completed | Effects of Tibolone Treatment on the Endometrium NCT00294463 | Erasmus Medical Center | Phase 4 |
| Completed | Phytoestrogens and Memory Decline in Menopause NCT00051402 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Fat Distribution in Healthy Early Postmenopausal Women NCT00335218 | Bayer | Phase 4 |
| Completed | Reduction of Triglycerides in Women on Hormone Replacement Therapy NCT00023543 | University of Pittsburgh | Phase 2 |
| Completed | A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women NCT00152295 | Abbott | Phase 2 |
| Completed | Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause NCT00009659 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 2 |
| Completed | Postmenopausal Women Estrogen and Progesterone Infusion NCT00455741 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal W NCT00152282 | Abbott | Phase 2 |
| Completed | Sex Steroid Hormones and Risk of CHD in Women NCT00006407 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | AFTER: Altering Fat Through Estrogen and Raloxifene NCT00149604 | National Institute on Aging (NIA) | Phase 2 |
| Completed | Thrombotic, Inflammatory & Gene Markers of CVD in Women NCT00006539 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Effects of Black Cohosh on Menopausal Hot Flashes NCT00010712 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Hormone Therapy Effects on CVD Risk Factors NCT00006313 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections NCT00001890 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Mutations, Hormone Therapy (HRT) and Venous Thromboembolism NCT00005515 | University of Washington | — |
| Completed | Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women NCT00001752 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Midlife Cholesterol Study NCT00361075 | Northwestern University | Phase 4 |
| Completed | CVD Risk and Health in Postmenopausal Phytoestrogen Users NCT00000613 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Estrogen and Graft Atherosclerosis Research Trial (EAGER) NCT00000605 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Women's Angiographic Vitamin and Estrogen Trial (WAVE) NCT00000555 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Postmenopausal Hormone Therapy in Unstable Angina NCT00000601 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART) NCT00000559 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Estrogen Replacement and Atherosclerosis (ERA) in Older Women NCT00000549 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Endogenous Estrogen and Coronary Heart Disease in Women NCT00005446 | NYU Langone Health | — |
| Completed | EPAT: Estrogen in the Prevention of Atherosclerosis Trial NCT00115024 | National Institute on Aging (NIA) | Phase 2 / Phase 3 |
| Completed | Lifestyle Management for Women With CHD and NIDDM NCT00005441 | Oregon Research Institute | — |
| Completed | Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause NCT00000532 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Women's Health Trial: Feasibility Study in Minority Populations NCT00000481 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Stroke and MI in Users of Estrogen/Progestogen NCT00005466 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Diet and Exercise for Elevated Risk (DEER) NCT00000598 | Stanford University | Phase 3 |
| Completed | Postmenopausal Progestins, MI and Stroke NCT00005220 | University of Washington | — |
| Completed | Postmenopausal Estrogen/Progestin Interventions (PEPI) NCT00000466 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Myocardial Infarction and Non-contraceptive Estrogen Use NCT00005185 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Myocardial Infarction and Past Oral Contraceptive Use NCT00005173 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Active Not Recruiting | Nurses' Health Study (Cardiovascular Component) NCT00005152 | Brigham and Women's Hospital | — |
| Completed | Women's Health Initiative (WHI) NCT00000611 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste NCT00029757 | National Center for Research Resources (NCRR) | N/A |